Ballentine Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$707K Sell
9,842
-1,029
-9% -$96.9K 0.01% 454
2026
Q1
$1.29M Buy
10,871
+1,425
+15% +$176K 0.02% 295
2025
Q4
$1.19M Sell
9,446
-2,407
-20% -$314K 0.02% 290
2025
Q3
$1.73M Buy
11,853
+276
+2% +$41.7K 0.02% 222
2025
Q2
$1.81M Sell
11,577
-706
-6% -$112K 0.03% 209
2025
Q1
$2.02M Buy
12,283
+132
+1% +$22K 0.04% 183
2024
Q4
$1.98M Buy
12,151
+357
+3% +$63.8K 0.03% 177
2024
Q3
$2.3M Sell
11,794
-2
-0% -$369 0.04% 154
2024
Q2
$2.04M Sell
11,796
-137
-1% -$22.8K 0.04% 154
2024
Q1
$2.02M Sell
11,933
-107
-0.9% -$20K 0.04% 153
2023
Q4
$2.38M Buy
12,040
+2,138
+22% +$378K 0.05% 129
2023
Q3
$1.72M Buy
9,902
+141
+1% +$25.6K 0.04% 138
2023
Q2
$1.68M Sell
9,761
-2,116
-18% -$366K 0.04% 137
2023
Q1
$1.98M Buy
11,877
+2,450
+26% +$402K 0.05% 129
2022
Q4
$1.38M Buy
9,427
+186
+2% +$27.5K 0.04% 135
2022
Q3
$1.37M Buy
9,241
+674
+8% +$113K 0.05% 122
2022
Q2
$1.47M Buy
8,567
+12
+0.1% +$2.08K 0.05% 121
2022
Q1
$1.61M Buy
8,555
+22
+0.3% +$4.35K 0.05% 122
2021
Q4
$2.08M Buy
8,533
+367
+4% +$80.4K 0.06% 106
2021
Q3
$1.58M Buy
8,166
+25
+0.3% +$5.04K 0.05% 114
2021
Q2
$1.52M Buy
8,141
+1,328
+19% +$231K 0.05% 114
2021
Q1
$1.07M Sell
6,813
-199
-3% -$31.5K 0.04% 146
2020
Q4
$1.16M Sell
7,012
-272
-4% -$44.2K 0.05% 135
2020
Q3
$1.21M Sell
7,284
-2,278
-24% -$350K 0.05% 121
2020
Q2
$1.31M Buy
9,562
+6,594
+222% +$861K 0.06% 112
2020
Q1
$350K Buy
2,968
+250
+9% +$32.9K 0.02% 228
2019
Q4
$360K Buy
2,718
+44
+2% +$5.47K 0.02% 270
2019
Q3
$333K Sell
2,674
-81
-3% -$9.78K 0.02% 275
2019
Q2
$312K Buy
+2,755
New +$289K 0.02% 285
2018
Q4
Sell
-2,213
Closed -$203K 385
2018
Q3
$203K Buy
+2,213
New +$196K 0.01% 338

Other funds holding ZTS

Ballentine Partners's ZTS Position: Q2 2026 in Review

Ballentine Partners reduced its Zoetis (ZTS) stake by 9.5% in Q2 2026, selling an estimated $96.9K and leaving 9,842 shares worth $707K. The position accounts for 0.01% of the portfolio, ranked #454.

Ballentine Partners first reported a position in ZTS in Q3 2018 and has held it in 30 quarters since. The position peaked at $2.38M in Q4 2023. 224 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Ballentine Partners held 9,842 shares of Zoetis worth $707K as of Q2 2026.
  • Ballentine Partners sold 1,029 Zoetis shares in Q2 2026, an estimated $96.9K.
  • Zoetis made up 0.01% of Ballentine Partners's portfolio in Q2 2026, its #454 holding.
  • Ballentine Partners first reported a position in Zoetis in Q3 2018 and has held it in 30 quarters since.
  • Ballentine Partners's Zoetis position peaked at $2.38M in Q4 2023.
  • 224 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.